Atea Pharmaceuticals (AVIR) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 18, 2026, with voting available online or virtually.

• Shareholders are encouraged to review proxy materials and vote by June 17, 2026.

Voting matters and shareholder proposals

• Election of three Class III directors: Jerome Adams, Howard Berman, and Barbara Duncan, with board recommending a vote in favor.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory (non-binding) approval of named executive officer compensation, with board recommending a vote in favor.

• Provision for other business to be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends all director nominees for election to Class III positions.